It has also been reported that cancer cells addicted to tyrosine kinase inhibitors (TKI) displayed a metabolic shift toward increased glycolysis and lactate production, which induced cancer-associated fibroblasts to produce hepatocyte growth factor (HGF) to activate MET-dependent signaling in cancer cells, and ultimately sustained resistance to TKIs [65]. The gene discussed is MET; the disease is cancer.